Bryophyllum vs. Nifedipine

Phase 2

• Conditions: Tocolysis

• Registration Number: NCT00391339
• Lead Sponsor: Weleda AG

Brief Summary

In a prospective, randomised study the efficacy and tolerability of bryophyllum p. (p.o) vs. nifedipine (p.o) will be proofed in a defined group of pregnant women with threatened preterm labour.

Detailed Description

Not available

Study Timeline

• Status Verified: 2006-10
• Study First Submitted: 2006-10-19
• Study First Submitted QC: 2006-10-19
• Last Update Submitted: 2006-10-19
• Study First Posted: 2006-10-23
• Last Update Posted: 2006-10-23
• Study Start: 2006-11
• Study Completion: 2008-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 140

Inclusion Criteria

• Female

Exclusion Criteria

• Bishop Score > 5

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Department of Obstetrics, University of Zuerich; 🇨🇭 Zuerich, Switzerland